|
|
Volumn 349, Issue , 2014, Pages g5488-
|
|
US signs contract with ZMapp maker to accelerate development of the Ebola drug
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
ZMAPP;
DRUG APPROVAL;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
HEMORRHAGIC FEVER, EBOLA;
HUMAN;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
CONTRACT SERVICES;
DRUG APPROVAL;
DRUG DISCOVERY;
DRUG INDUSTRY;
FINANCING, GOVERNMENT;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
UNITED STATES;
|
|
EID: 84912064043
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g5488 Document Type: Note |
|
Times cited : (64)
|
|
References (0)
|